Changes in pharmacokinetic profiles of acetaminophen and its glucuronide after pretreatment with combinations of N-acetylcysteine and either glycyrrhizin, silibinin or spironolactone in rat

References

• Aleksunes LM, Slitt AL, Maher JM, et al. (2008). Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol Appl Pharmacol 226:74–83
   PubMed Web of Science ®Google Scholar
• Bohnenstengel F, Kroemer HK, Sperker B. (1999). In vitro cleavage of paracetamol glucuronide by human liver and kidney beta-glucuronidase: determination of paracetamol by capillary electrophoresis. J Chromatogr B Biomed Sci Appl 721:295–9
   PubMed Web of Science ®Google Scholar
• Chen C, Hennig GE, Manautou JE. (2003). Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. Drug Metab Dispos 31:798–804
   PubMed Web of Science ®Google Scholar
• Crocenzi FA, Roma MG. (2006). Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication. Curr Med Chem 13:1055–74
   PubMed Web of Science ®Google Scholar
• Ezhilarasan D, Karthikeyan S, Vivekanandan P. (2012). Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats. Environ Toxicol Pharmacol 34:1004–13
   PubMed Web of Science ®Google Scholar
• Ghanem CI, Ruiz ML, Villanueva SS, et al. (2005). Shift from biliary to urinary elimination of acetaminophen-glucuronide in acetaminophen-pretreated rats. J Pharmacol Exp Ther 315:987–95
   PubMed Web of Science ®Google Scholar
• Hau DK, Wong RS, Cheng GY, et al. (2010). Novel use of silymarin as delayed therapy for acetaminophen-induced acute hepatic injury. Forsch Komplementmed 17:209–13
   PubMedGoogle Scholar
• Horikawa M, Kato Y, Tyson CA, Sugiyama Y. (2002). The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet 17:23–33
   PubMedGoogle Scholar
• Howie D, Adriaenssens PI, Prescott LF. (1977). Paracetamol metabolism following overdosage: application of high performance liquid chromatography. J Pharm Pharmacol 29:235–7
   PubMed Web of Science ®Google Scholar
• Jaeschke H. (2005). Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 1:389–97
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Bajt ML. (2006). Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 89:31–41
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Knight TR, Bajt ML. (2003). The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol Lett 144:279–88
   PubMed Web of Science ®Google Scholar
• Kim SW, Jin Y, Shin JH, et al. (2012). Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiol Dis 46:147–56
   PubMed Web of Science ®Google Scholar
• Lauterburg BH, Corcoran GB, Mitchell JR. (1983). Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 71:980–91
   PubMed Web of Science ®Google Scholar
• Lickteig AJ, Fisher CD, Augustine LM, et al. (2007). Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metab Dispos 35:1970–8
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Mao Q, Klaassen CD. (1994). The effects of 10 triterpenoid compounds on experimental liver injury in mice. Fundam Appl Toxicol 22:34–40
   PubMedGoogle Scholar
• Mitchell JR, Jollow DJ, Potter WZ, et al. (1973). Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187:211–17
   PubMed Web of Science ®Google Scholar
• Moldeus P. (1978). Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse. Biochem Pharmacol 27:2859–63
   PubMed Web of Science ®Google Scholar
• Ni YF, Kuai JK, Lu ZF, et al. (2011). Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression. J Surg Res 165:e29–35
   PubMed Web of Science ®Google Scholar
• Ochs HR, Greenblatt DJ, Bodem G, Smith TW. (1978). Spironolactone. Am Heart J 96:389–400
   PubMed Web of Science ®Google Scholar
• Rowden AK, Norvell J, Eldridge DL, Kirk MA. (2006). Acetaminophen poisoning. Clin Lab Med 26:49–65, viii
   PubMed Web of Science ®Google Scholar
• Ruiz ML, Villanueva SS, Luquita MG, et al. (2007). Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2. Drug Metab Dispos 35:2060–6
   PubMed Web of Science ®Google Scholar
• Shen C, Zhang G, Qiu H, Meng Q. (2006). Acetaminophen-induced hepatotoxicity of gel entrapped rat hepatocytes in hollow fibers. Chem Biol Interact 162:53–61
   PubMed Web of Science ®Google Scholar
• Souza CO, Peracoli MT, Weel IC, et al. (2012). Hepatoprotective and anti-inflammatory effects of silibinin on experimental preeclampsia induced by L-NAME in rats. Life Sci 91:159–65
   PubMed Web of Science ®Google Scholar
• Wan XY, Luo M, Li XD, He P. (2009). Hepatoprotective and anti-hepatocarcinogenic effects of glycyrrhizin and matrine. Chem Biol Interact 181:15–19
   PubMed Web of Science ®Google Scholar
• Williams CD, Farhood A, Jaeschke H. (2010). Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury. Toxicol Appl Pharmacol 247:169–78
   PubMed Web of Science ®Google Scholar
• Xu R, Zhang X, Yang J, et al. (2012). Effects of glycyrrhizin on biliary transport and hepatic levels of glutathione in rats. Biopharm Drug Dispos 33:235–45
   PubMed Web of Science ®Google Scholar